2024 ASCO Direct™ Salt Lake City
Learn How to Claim Your Credit
On-demand content coming soon!
Total Health in partnership with the Society of Utah Medical Oncologists (SUMO) is excited to bring you the 2024 ASCO Direct™ Salt Lake City. This free, two-day, in-person conference is an officially licensed ASCO Direct meeting. We will showcase the ‘Best of’ abstracts selected from the 2024 ASCO Annual Meeting, allowing attendees to learn and incorporate the latest research and clinical strategies in their practice.
Accreditation Information | 7.25
In support of improving patient care, this activity has been planned and implemented by Amedco LLC and Total Health. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
-
Amedco LLC designates this activity for a maximum of 7.25 ANCC contact hours.
-
Amedco LLC designates this live activity for a maximum of 7.25 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
-
Amedco LLC designates this activity for a maximum of 7.25 knowledge-based CPE contact hours.
NOTE to Pharmacists: The only official Statement of Credit is the one you pull from CPE Monitor. You must request your certificate within 30 days of your participation in the activity to meet the deadline for submission to CPE Monitor.
-
Acknowledgment of Financial Commercial Support
No financial commercial support was received for this educational activity.
Acknowledgement of In-Kind Commercial Support
No in-kind commercial support was received for this educational activity.
Satisfactory Completion
Learners must complete an evaluation form to receive a certificate of completion. Your chosen sessions must be
attended in their entirety. You must attend the entire webinar as partial credit is not available. If you are seeking continuing education credit for a specialty not listed below, it is your responsibility to contact your licensing/certification board to determine course eligibility for your licensing/certification requirement.
Joint Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by
Amedco LLC and Total Health Conferences. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Amedco Joint Accreditation Provider Number: 4008163
Physicians
ACCME Credit Designation Statement
Amedco LLC designates this live activity for a maximum of 7.25 AMA PRA Category 1 CreditsTM for physicians.
Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Pharmacists & Pharmacy Technicians
ACPE Credit Designation Statement
Amedco LLC designates this activity for a maximum of 7.25 knowledge-based CPE contact hours.
JA4008163-9999-24-047-L01-P | JA4008163-9999-24-047-L01-T
NOTE to Pharmacists: The only official Statement of Credit is the one you pull from CPE Monitor. You must request your certificate within 45 days of your participation in the activity to meet the deadline for submission to CPE Monitor.
Credits are generally reported during the first week of each month for those who claimed during the month prior.
Nurses
ANCC Credit Designation Statement
Amedco LLC designates this activity for a maximum of 7.25 ANCC contact hours.
Learner Notification Objectives - After Attending This Program You Should Be Able To
1. Integrate new evidence into everyday clinical practice, thereby improving the quality of care being delivered to patients living with and beyond cancer
2. Implement practice changes in a variety of treatment options for solid tumors, including lung, breast, melanomas, colorectal, non-colorectal GI, and GU Cancers
3. Stimulate innovative strategies for new and additional research related to treatment and prevention
Disclosure of Conflict of Interest
The following table of disclosure information is provided to learners and contains the relevant financial relationships that each individual in a position to control the content disclosed to Amedco. All of these relationships were treated as a conflict of interest, and have been resolved. (C7 SCS 6.1-6.2, 6.5)
All individuals in a position to control the content of CE are listed below.
Name and Commercial Interest: Relationship
Wallace Akerley NA
Jessica Gentile NA
John Goerke NA
Matthew Gumbleton NA
Siwen Hu-Lieskovan NA
Bradley Huntere
Kite Pharma, AbbVie, Genmab:Speakers Bureau
Kite Pharma, AbbVie, Genmab, Johnson & Johnson, BMS, Novartis, In8 Bio,
Genentech, ADC Therapeutics:Consultant
Notable Labs, Astellas, Regeneron - Consultant
Laura Huppert Pfizer, AstraZeneca:Scientific/Medical Advisory Board Member
Tirrell Johnson NA
Kevin Kalinsky
Grail, Pfizer, Array BioPharma:Research Grant Overall Principal Investigator
EEli-Lilly, Pfizer, Novartis, Eisai, AstraZeneca, Immunomedics, Merck, Seattle
Genetics, and Cyclocel:Consultant
Carrie Ann Kemp NA
Katie Kerrigan
Genentech, Sanofi:Speakers Bureau
AstraZeneca:Scientific/Medical Advisory Board Member
Ravi Madan NA
Sami Mansfield NA
Kelly McAleer NA
Ariel Perez Perez
Gilead Kite:Speakers Bureau
AbbVie:Consultant
Mohamed Salem NA
Scott Samuelson NA
Douglas Sborov
GlaxoSmithKline, Janssen, Sanofi, Abbvie, Bristol Myer Squibb, Pfizer, Arcellx,
Genentech, AstraZeneca, Bioline:Consultant
Pfizer:Research Grant Overall Principal Investigator
Karyopharm:Scientific/Medical Advisory Board Member
Lee Schwartzberg
AstraZeneca, Napo, GlaxoSmithKline, Pfizer, Coherus, Helsinn, Novartis,
Spectrum, Daiichi Sankyo:Consultant
Seagen, Foundation Medicine, Merck:Speakers Bureau
Nagashree Seetharamu
Genentech, Vaccinex, Amgen, Merck:Research Grant Overall Principal Investigator
Astra Zeneca, Genentech, Takeda, Amgen, Pfizer, Mirati,
BluePrint:Scientific/Medical Advisory Board Member
Boehringer Ingram:Consultant
Prashant Sharma NA
Heloisa Soares
Ipsen, Novartis, Exelixis:Consultant
ITM:Other
Umang Swami
Astellas, Seattle Genetics, Exelixis, Imvax, Sanofi, Pfizer, AstraZeneca,
Gilead:Consultant
Astellas, Seattle Genetics, Janssen, Exelixis:Research Grant Overall Principal
Investigator
STACY WENTWORTH Varian Medical Systems, Horizon CME:Speakers Bureau
Reyna Wilhelm NA
Justin Kaiser NA
How to Get Your Certificate
For ACCME, ANCC, ACPE click on the ASCO Salt Lake City 2024 link.
For ABIM MOC click on the ASCO Salt Lake City 2024 ABIM MOC link.
Evaluate the meeting.
Print, download, or save your certificate for your records.
If you lose your certificate, or need help, go to help.cmecertificateonline.com